Skip to main content

. 1987 Nov;147(5):593–596.

Hypernatremia associated with cathartics in overdose management.

J W Caldwell, A J Nava, D D de Haas

PMCID: PMC1025962 PMID: 3424825

593

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Berg M. J., Berlinger W. G., Goldberg M. J., Spector R., Johnson G. F. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med. 1982 Sep 9;307(11):642–644. doi: 10.1056/NEJM198209093071102. [DOI] [PubMed] [Google Scholar]
Berlinger W. G., Spector R., Goldberg M. J., Johnson G. F., Quee C. K., Berg M. J. Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther. 1983 Mar;33(3):351–354. doi: 10.1038/clpt.1983.44. [DOI] [PubMed] [Google Scholar]
Brown J. L. Incomplete labeling of pharmaceuticals: a list of "inactive" ingredients. N Engl J Med. 1983 Aug 18;309(7):439–441. doi: 10.1056/NEJM198308183090726. [DOI] [PubMed] [Google Scholar]
Hill R. E., Kamath K. R. "Pink" diarrhoea: osmotic diarrhoea from a sorbitol-containing vitamin C supplement. Med J Aust. 1982 May 1;1(9):387–389. doi: 10.5694/j.1326-5377.1982.tb132375.x. [DOI] [PubMed] [Google Scholar]
Krenzelok E. P., Keller R., Stewart R. D. Gastrointestinal transit times of cathartics combined with charcoal. Ann Emerg Med. 1985 Dec;14(12):1152–1155. doi: 10.1016/s0196-0644(85)81019-2. [DOI] [PubMed] [Google Scholar]
Levy G. Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med. 1982 Sep 9;307(11):676–678. doi: 10.1056/NEJM198209093071109. [DOI] [PubMed] [Google Scholar]
Minocha A., Herold D. A., Bruns D. E., Spyker D. A. Effect of activated charcoal in 70% sorbitol in healthy individuals. J Toxicol Clin Toxicol. 1984;22(6):529–536. doi: 10.3109/15563658408992582. [DOI] [PubMed] [Google Scholar]
Neuvonen P. J. Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clin Pharmacokinet. 1982 Nov-Dec;7(6):465–489. doi: 10.2165/00003088-198207060-00001. [DOI] [PubMed] [Google Scholar]
Neuvonen P. J., Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol. 1980 Jan;17(1):51–57. doi: 10.1007/BF00561677. [DOI] [PubMed] [Google Scholar]
Picchioni A. L., Chin L., Gillespie T. Evaluation of activated charcoal-sorbitol suspension as an antidote. J Toxicol Clin Toxicol. 1982 Jul;19(5):433–444. doi: 10.3109/15563658208992498. [DOI] [PubMed] [Google Scholar]
Pond S., Jacobs M., Marks J., Garner J., Goldschlager N., Hansen D. Treatment of digitoxin overdose with oral activated charcoal. Lancet. 1981 Nov 21;2(8256):1177–1178. doi: 10.1016/s0140-6736(81)90632-2. [DOI] [PubMed] [Google Scholar]
Spyker D. A. Activated charcoal reborn. Progress in poison management. Arch Intern Med. 1985 Jan;145(1):43–44. [PubMed] [Google Scholar]

ACTIONS

PDF (1.1 MB)

RESOURCES